NL-OMON32199
Not Yet Recruiting
Phase 2
Acute cardiac resynchronization therapy for right ventricular disease - Resynchronization therapy for right ventricular disease
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- pulmonary hypertension
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 30
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult CTEPH patients who undergo right heart catheterization to obtain hemodynamic data as part of the regular diagnostic workup to assess their eligibility for pulmonary endarterectomy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Acute cardiac resynchronization therapy for chronic thromboembolic pulmonary hypertensiopulmonary hypertensionright ventricular failure10019280NL-OMON32814Academisch Medisch Centrum30
Completed
N/A
Resynchronisation/defibrillation for Ambulatory heart Failure TrialCongestive heart failureCirculatory SystemISRCTN16587532niversity of Ottawa Heart Institute (Canada)1,800
Completed
N/A
on-responders of cardiac resynchronization therapy: the effect of left ventricular endocardial pacing and simulated exercise on acute hemodynamic responseheart failure NYHA class III or IVsevere heart failure10019280NL-OMON32988Catharina-ziekenhuis50
Completed
N/A
Optimizing cardiac resynchronization therapy with the use of an implantable heart monitorNL-OMON42377Academisch Medisch Centrum20
Completed
N/A
More Response on Cardiac Resynchronization Therapy (CRT) with MultiPoint Pacing (MPP)*Cardiac dyssynchronyHeart Failure10019280NL-OMON47405St. Jude Medical350